Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Channel Therapeutics Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q2 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q4 2025 | 1 | -$0.25 | -$0.25 | -$0.25 |
Channel Therapeutics Corporation Earnings Date And Information
Channel Therapeutics Corporation last posted its earnings results on Thursday, March 27th, 2025. The company reported $-0.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $0.11. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Channel Therapeutics Corporation has generated $-1 earnings per share over the last year ($-1.43 diluted earnings per share) and currently has a price-to-earnings ratio of -1.02. Channel Therapeutics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 28th, 2025 based on prior year's report dates.
Channel Therapeutics Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/27/2025 | Q4 2024 | -$0.21 | -$0.34 | -0.13 | $0 | $0 |
| 11/13/2024 | Q3 2024 | -$0.23 | -$0.29 | -0.06 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.31 | -$0.31 | 0 | $0 | $0 |
| 05/15/2024 | Q1 2024 | N/A | -$0.44 | N/A | N/A | $0 |
| 04/16/2024 | Q4 2023 | N/A | -$0.69 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.25 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.17 | N/A | N/A | $0 |
| 12/29/2022 | Q4 2022 | N/A | -$0.13 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$0.10 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$0.06 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$0.05 | N/A | N/A | $0 |
| 12/31/2021 | Q4 2021 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | $0.00 | N/A | N/A | $234 |
| 06/30/2021 | Q2 2021 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | $0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Channel Therapeutics Corporation Earnings: FAQ's
Channel Therapeutics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 28th, 2025 based offlast year's report dates.
The conference call for Channel Therapeutics Corporation's latest earnings report can be listened to online.
The conference call transcript for Channel Therapeutics Corporation's latest earnings report can be read online.
Channel Therapeutics Corporation (:CHRO) has a recorded net income of $-7,955,338.Channel Therapeutics Corporation has generated $-1.43 earnings per share over the last four quarters.
Channel Therapeutics Corporation (:CHRO) has a price-to-earnings ratio of -1.02 and price/earnings-to-growth ratio is -0.05.